U.S. Media Stock News

NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Pharmaceuticals (AMRX) Wins FDA Nod For Iohexol, Is The Upside Already Priced In?

Amneal Pharmaceuticals (AMRX) has drawn fresh attention after receiving U.S. Food and Drug Administration approval for additional strengths and vial sizes of its iohexol injection, which expands its radiographic contrast agent offering. See our latest analysis for Amneal Pharmaceuticals. The FDA approval arrives at a time when Amneal Pharmaceuticals’ share price momentum is strong, with a 30 day share price return of 10.47% and a year to date share price return of 50.87%, alongside a 1 year...
NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Could Be 31% Undervalued After Softer Q2 Earnings

Why PulteGroup Stock Is Back In Focus After Q2 Results PulteGroup (PHM) moved into the spotlight after reporting second quarter 2026 earnings that showed lower revenue and net income compared with the same period a year earlier, alongside an update on its long running share repurchase program. See our latest analysis for PulteGroup. At a share price of $132.31, PulteGroup has seen its 7 day share price return rise 4.39% while the 30 day return is down 4.08%. The 1 year total shareholder...
NYSE:TRIN
NYSE:TRINCapital Markets

Trinity Capital (TRIN) Left The NASDAQ Composite, Is The Stock Still Undervalued?

Trinity Capital (TRIN) was removed from the NASDAQ Composite Index on 24 July 2026. This event can prompt index tracking funds and benchmarked portfolios to adjust holdings and reassess exposure to the stock. See our latest analysis for Trinity Capital. Trinity Capital's removal from the NASDAQ Composite comes after a period where the share price rose 16.74% year to date and the 1 year total shareholder return reached 35.24%. This points to momentum that has built over a longer horizon, even...
NYSE:TGLS
NYSE:TGLSBuilding

Tecnoglass (TGLS) Stock Still Looks Below Fair Value On Its 150% Five Year Run

Tecnoglass stock has given shareholders a strong 150.1% return over the past 5 years, yet its recent slide and mixed valuation checks raise questions about how the current price stacks up against fundamentals. After a 40.9% decline over the past year and a year to date return that is down 13.8%, the focus now is whether the recent level around US$44.88 still offers value or mainly reflects past gains. Over 5 years Tecnoglass has returned 150.1%, which puts the recent share price weakness...
NasdaqGS:QBTS
NasdaqGS:QBTSSoftware

D Wave Quantum (QBTS) On AT And T Expansion And Index Inclusion Is The Stock A Bargain

Index inclusion and new enterprise demand put D-Wave Quantum in focus D-Wave Quantum (QBTS) has been added to the NASDAQ Composite Index shortly after AT&T expanded its use of the company’s quantum computing technology across key network optimization workloads. See our latest analysis for D-Wave Quantum. For context, D-Wave Quantum’s share price has eased despite the index inclusion and new AT&T agreement. The stock is down 32.10% on a 30 day share price return and 42.48% year to date, while...
NYSE:GM
NYSE:GMAuto

General Motors Stock And 2 Auto Names After The Stellantis Earnings Shock

The latest Stellantis earnings update shows how quickly sentiment can swing when results and expectations do not line up. Net profit moved to €293 million in Q2 from a loss of €1.87 billion a year earlier, and adjusted operating income reached €773 million. However, the stock still fell as much as 8% on the day because the figure came in below the €914 million consensus. That kind of reaction can ripple across North American auto manufacturers. This article looks at 3 stocks exposed to that...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Should Walmart’s (WMT) Expanding Brand Partnerships and Ad Tools Shape Its AI-Driven Omni-Channel Story?

In recent weeks, a series of partner announcements has expanded Walmart’s assortment and ecosystem exposure, from Kate Farms’ High Protein Nutrition Shake rollout across more than 6,800 Walmart and CVS locations to Edible Garden’s fresh herb expansion in Mid-Atlantic stores and Final Boss Sour’s planned entry into Walmart’s shelves. At the same time, integration into tools like Shirofune’s Walmart Connect interface and a reported investor rotation toward defensive retailers underline how...
NYSE:CMG
NYSE:CMGHospitality

Chipotle (CMG) Stock May Trade At A Premium As Earnings Top Views

Chipotle Mexican Grill stock has fallen 21.8% over the past year, while the latest Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a premium to that model and the broader valuation checks also lean expensive rather than clearly cheap. The 21.8% share price decline over the last 12 months leaves investors weighing up whether the recent weakness has already reflected the main concerns in Chipotle Mexican Grill's valuation. Expectations around future...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing

The Federal Trade Commission, Utah, and Los Angeles County filed a lawsuit against Hims & Hers Health (NYSE:HIMS) alleging unauthorized sharing of sensitive health data and deceptive billing practices. The complaint focuses on how the company handled patient information on its telehealth platform and how subscriptions and cancellations were billed and processed. The action highlights potential regulatory and reputational risks for Hims & Hers Health that investors may weigh when assessing...
NYSE:NEM
NYSE:NEMMetals and Mining

3 U.S. Value Stocks To Watch As Higher Oil And Rates Stir Markets

The latest 1,000 point drop in the Dow after the Federal Reserve held interest rates steady has put value stocks back under the spotlight. With inflation still above target and U.S. oil prices near US$85 per barrel, many investors are taking a fresh look at large U.S. companies that already trade on lower price ratios and have some dividend history. This article focuses on three U.S. Large Cap Value Stocks from our screener that appear more directly exposed to the current rate and oil...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express (AXP) Trades 12% Below Fair Value As Revenue Guidance Rises

American Express (AXP) is back in focus after reporting record card member spending growth, raising its full year revenue guidance, and choosing to channel earnings outperformance into growth initiatives instead of faster share repurchases. See our latest analysis for American Express. Despite the upbeat guidance and record spending, American Express shares have pulled back, with a 7 day share price return of 4.94% and a year to date share price decline of 11.06% at a last close of US$331.50...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Pharmaceutical Industries (TEVA) Raises Revenue Guidance, Is The 15% Undervaluation Still There?

Teva Pharmaceutical Industries (NYSE:TEVA) stock is reacting to a mixed update after the company raised its 2026 revenue guidance while reporting a quarterly net loss and new asset impairment charges. See our latest analysis for Teva Pharmaceutical Industries. The earnings update and higher 2026 revenue guidance have arrived alongside sharp share price swings, with a 1 day share price return of 9.6% and a 7 day share price return of 15.1%. Over a longer horizon, the 1 year total shareholder...
NYSE:AIR
NYSE:AIRAerospace & Defense

AAR (AIR) Is Up 6.1% After Robust Q4 Earnings And New Shelf Filing - Has The Bull Case Changed?

AAR Corp. recently reported fourth-quarter 2026 results showing sales of US$928 million and net income of US$50.7 million, alongside a completed US$107.54 million share repurchase program that retired 2,429,700 shares under its 2021 authorization. The company also filed an omnibus shelf registration covering multiple security types, giving it broad flexibility to raise capital after a year in which full-year earnings per share from continuing operations increased markedly. We’ll now examine...
NasdaqGS:SPCX
NasdaqGS:SPCXTelecom

Space Exploration Technologies (SPCX) Slides Before Earnings, Is The Valuation Gap Too Wide?

Space Exploration Technologies (SPCX) has seen its stock lose more than US$1.2b in market value since a June peak, with shares recently under pressure ahead of its first post IPO earnings report on August 4. See our latest analysis for Space Exploration Technologies. The recent slide leaves Space Exploration Technologies with a 1 day share price return of 3.32% lower, a 7 day share price return of 4.81% lower and a 30 day share price return of 34.13% lower. Recent momentum has clearly faded...
NYSE:XPO
NYSE:XPOTransportation

XPO (XPO) Adds Former United Rentals CEO Michael Kneeland To Its Board

Michael Kneeland, former CEO and current non executive chairman of United Rentals, has joined the board of directors of NYSE:XPO. Kneeland brings leadership experience in industrial services, equipment rental and logistics related businesses. This appointment marks a recent change in XPO's board composition and governance structure. XPO operates in freight transportation and logistics, a sector that depends heavily on operational efficiency, capital discipline and consistent service...
NYSE:GRMN
NYSE:GRMNConsumer Durables

US Stock Market Today: S&P 500 Futures Edge Higher As Fed And Oil Risks Loom

The Morning Bull - US Market Morning Update Thursday, Jul, 30 2026 US market stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.3%, as investors weigh interest rate risks and energy prices. The US 10 year Treasury yield is steady ahead of the Federal Reserve meeting, where markets see roughly a one in three chance of a rate hike now and about 80% odds in September. That reflects concern that Middle East related oil price moves could keep...
NYSE:ARDT
NYSE:ARDTHealthcare

Ardent Health (ARDT) Faces An Earnings Test As Undervalued Narrative Holds

Upcoming earnings set the tone for Ardent Health stock Ardent Health (ARDT) is back in focus as investors weigh expectations for its June 2026 quarter. Forecasts point to lower revenue and earnings, yet models still point to a possible upside EPS surprise. See our latest analysis for Ardent Health. The share price of Ardent Health has pulled back 4.7% over the last day. However, the 30 day share price return of 10.1% and year to date share price return of 26.5% point to building momentum...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Earnings Beat Puts Its Valuation Back In Focus

Why Modine Manufacturing Stock Is Back in Focus After Q1 Earnings Modine Manufacturing (MOD) is attracting fresh attention after reporting first quarter results on July 29, 2026, with earnings per share and net income ahead of the prior year and new guidance for fiscal 2027. See our latest analysis for Modine Manufacturing. Despite Modine Manufacturing reporting higher Q1 sales and net income on July 29 and issuing new fiscal 2027 guidance, the share price has dropped 30.6% over the past...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog (DDOG) Stock Looks Fairly Valued On Cash Flow Yet Rich On Sales

Datadog stock has delivered strong multi year gains, yet current valuation checks suggest it no longer looks obviously cheap. The intrinsic value estimate from a Discounted Cash Flow (DCF) model sits close to the recent share price, while market based multiples lean expensive. Over the past 3 years, Datadog has returned 147.3%, which puts extra focus on whether the current share price is already pricing in ambitious growth expectations. The new partnership bringing Cloudaware LogSight to the...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is Intel’s (INTC) Agentic AI PC Push Quietly Redefining Its Edge‑to‑Cloud Strategy?

In late July 2026, mimik Technology announced a collaboration with Intel to optimize its mimOE Agentix Operating Engine for Intel-powered AI PCs, enabling device-first, cloud-like governance and security for Agentic AI workloads across PCs, edge, and data centers. Alongside this, Intel’s memorandum with Lens Technology on glass-based advanced packaging and its expanded Arizona production plans highlight a push to tighten AI hardware, packaging, and on-device software into a more integrated...
NYSE:RSG
NYSE:RSGCommercial Services

Is Republic Services (RSG) A Bargain Following Strike Authorization And Labor Charges?

Republic Services (RSG) is back in focus after workers represented by Teamsters Local 104 unanimously voted to authorize a strike and filed an unfair labor practice charge, raising fresh questions around labor relations and potential operational risk. See our latest analysis for Republic Services. Republic Services shares recently closed at US$218.91, with short term momentum reflected in a 1 day share price return of 1.05% and a 90 day share price return of 4.63%, while the 1 year total...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Atour Lifestyle Holdings (ATAT) Draws Fresh Analyst Optimism, Is The Stock Still Undervalued?

Recent analyst reports on Atour Lifestyle Holdings (NasdaqGS:ATAT) have focused on upward revisions to earnings estimates and a Zacks Rank #1. This has drawn fresh attention to the stock within the leisure and recreation services sector. See our latest analysis for Atour Lifestyle Holdings. Atour Lifestyle Holdings has seen short term momentum pick up, with a 12.30% 7 day share price return and 9.31% 30 day share price return, although the share price is still down 11.39% year to date. The 3...
NYSE:CAT
NYSE:CATMachinery

Why Caterpillar (CAT) Is Down 12.0% After AI Data Center Demand Concerns And Regulatory Risks

Earlier this week, Baird downgraded Caterpillar after flagging growing U.S. state and local opposition to AI data center development that could slow future demand for its power generation equipment. This reassessment of data center–linked growth comes just as Caterpillar is expanding its role in AI infrastructure and facing fresh regulatory and supply chain questions, including new rare earth export restrictions from Beijing. We’ll now examine how rising regulatory pushback against AI data...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Will QURE’s AMT-130 Regulatory Momentum Offset Mounting Losses And Share Dilution Risk?

In the past week, uniQure N.V. reported Q2 2026 results showing revenue of US$5.84 million alongside a much larger quarterly net loss of US$81.06 million, while also filing a US$12.83 million shelf registration for 350,000 ordinary shares tied to its employee share plan. At the same time, the company advanced its regulatory plans for AMT-130 in Huntington’s disease and highlighted promising early data in epilepsy and Fabry programs, framing a contrast between widening losses and progress in...